TrialInternational journal of oncology2013

Phase II trial of dose-dense chemotherapy followed by dose-intense erlotinib for patients with newly diagnosed metastatic non-small cell lung cancer.

W Jeffrey Petty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.